Paradigm Genetics, TissueInformatics biomarker deal

PDGM and TissueInformatics (Pittsburgh, Penn.) will research biomarkers that signal the presence and progression of chronic liver disease. PDGM will perform metabolomics studies on tissue, urine and plasma to identify disease-specific biochemical profiles, and TissueInformatics will perform automated, quantitative analyses of tissue histopathology to identify disease-specific changes in tissue structure. ...